Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2016

Open Access 01-12-2016 | Research article

Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort study

Authors: Federica Edith Pisa, Giancarlo Logroscino, Paolo Giacomelli Battiston, Fabio Barbone

Published in: BMC Pulmonary Medicine | Issue 1/2016

Login to get access

Abstract

Background

Respiratory failure, infections and aspiration pneumonia, are the main causes of morbidity and mortality in Amyotrophic Lateral Sclerosis (ALS). In a population-based cohort, we assessed (a) hospital utilization and (b) impact of hospitalization for respiratory failure on survival.

Methods

All patients with incident ALS in Friuli Venezia Giulia region, Italy, from 2002 to 2009, were identified through multiple sources. Diagnosis was validated through clinical documentation review. For each patient, we extracted the records of all hospitalizations after ALS diagnosis from the regional hospitalization database. Cox proportional hazards model survival Hazard Ratio (HR), with 95 % Confidence Interval (95 % CI), was calculated.

Results

Out of 262 patients, 98.1 % had at least 1 and 58.0 % ≥3 hospitalizations. Emergency admissions occurred in 77.5 % of patients and a diagnosis of respiratory failure in 55.0 %. Patients underwent a total of 885 hospitalizations. The leading diagnosis was respiratory failure (31.6 % of hospitalizations). This diagnosis occurred most frequently in emergency (45.6 %) than in elective admissions (26.4 %). The second leading diagnosis was pneumonia (14.2 %), 24.9 and 6.3 % respectively. The leading procedure was mechanical ventilation (18.4 %), performed in 29.9 % of emergency and in 12.4 % of elective admissions. After adjustment for site of onset, age and diagnostic delay, a first hospitalization for respiratory failure had a strong adverse effect on survival (HR 4.00; 95 % CI 3.00; 5.34).

Conclusions

Respiratory failure, pneumonia and aspiration pneumonia were major determinants of hospitalizations and emergency admissions and often dealt with in emergency admissions. A first hospitalization for respiratory failure had a strong adverse effect on survival. Strategies to improve home management of respiratory conditions in patients with ALS and to optimize hospital care utilization are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marin B, Logroscino G, Boumediene F, Labrunie A, Couratier P, Babron MC, Leutenegger AL, Preux PM, Beghi E. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31(3):229-45. doi: 10.1007/s10654-015-0090-x. Epub 2015 Oct 12. Marin B, Logroscino G, Boumediene F, Labrunie A, Couratier P, Babron MC, Leutenegger AL, Preux PM, Beghi E. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31(3):229-45. doi: 10.​1007/​s10654-015-0090-x. Epub 2015 Oct 12.
2.
go back to reference Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5–6):310–23.CrossRefPubMedPubMedCentral Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5–6):310–23.CrossRefPubMedPubMedCentral
3.
go back to reference Capozzo R, Quaranta VN, Pellegrini F, Fontana A, Copetti M, Carratu P, Panza F, Cassano A, Falcone VA, Tortelli R, et al. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis. J Neurol. 2015;262(3):593–603. doi:10.1007/s00415-014-7613-3. Epub 2014 Dec 19.CrossRefPubMed Capozzo R, Quaranta VN, Pellegrini F, Fontana A, Copetti M, Carratu P, Panza F, Cassano A, Falcone VA, Tortelli R, et al. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis. J Neurol. 2015;262(3):593–603. doi:10.​1007/​s00415-014-7613-3. Epub 2014 Dec 19.CrossRefPubMed
4.
go back to reference Pena MJ, Ravasco P, Machado M, Pinto A, Pinto S, Rocha L, de Carvalho M, Pinto HC. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2012;13(6):550–4. doi:10.3109/17482968.2012.684215. Epub 2012 Jun 18.CrossRefPubMed Pena MJ, Ravasco P, Machado M, Pinto A, Pinto S, Rocha L, de Carvalho M, Pinto HC. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2012;13(6):550–4. doi:10.​3109/​17482968.​2012.​684215. Epub 2012 Jun 18.CrossRefPubMed
5.
go back to reference Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360–75. doi:10.1111/j.1468-1331.2011.03501.x. Epub 2011 Sep 14.CrossRefPubMed Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360–75. doi:10.​1111/​j.​1468-1331.​2011.​03501.​x. Epub 2011 Sep 14.CrossRefPubMed
6.
go back to reference Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–26. doi:10.1212/WNL.0b013e3181bc0141.CrossRefPubMedPubMedCentral Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–26. doi:10.​1212/​WNL.​0b013e3181bc0141​.CrossRefPubMedPubMedCentral
8.
go back to reference Veronese S, Valle A, Chio A, Calvo A, Oliver D. The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):499–504. doi:10.3109/21678421.2014.913637. Epub 2014 May 27.CrossRefPubMed Veronese S, Valle A, Chio A, Calvo A, Oliver D. The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):499–504. doi:10.​3109/​21678421.​2014.​913637. Epub 2014 May 27.CrossRefPubMed
9.
go back to reference Rabkin J, Ogino M, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, et al. Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3–4):185–91. doi:10.3109/21678421.2014.896928. Epub 2014 Apr 10.CrossRefPubMed Rabkin J, Ogino M, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, et al. Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3–4):185–91. doi:10.​3109/​21678421.​2014.​896928. Epub 2014 Apr 10.CrossRefPubMed
10.
go back to reference Chio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81(10):1141–3. doi:10.1136/jnnp.2009.175984. Epub 2010 Jul 26.CrossRefPubMed Chio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81(10):1141–3. doi:10.​1136/​jnnp.​2009.​175984. Epub 2010 Jul 26.CrossRefPubMed
11.
go back to reference Fini N, Georgoulopoulou E, Vinceti M, Monelli M, Pinelli G, Vacondio P, Giovannini M, Dallari R, Marudi A, Mandrioli J. Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy. Muscle Nerve. 2014;50(4):508–16. doi:10.1002/mus.24187. Epub 2014 Aug 5.CrossRefPubMed Fini N, Georgoulopoulou E, Vinceti M, Monelli M, Pinelli G, Vacondio P, Giovannini M, Dallari R, Marudi A, Mandrioli J. Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy. Muscle Nerve. 2014;50(4):508–16. doi:10.​1002/​mus.​24187. Epub 2014 Aug 5.CrossRefPubMed
14.
go back to reference Dubinsky R, Chen J, Lai SM. Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort. Neurology. 2006;67(5):777–80.CrossRefPubMed Dubinsky R, Chen J, Lai SM. Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort. Neurology. 2006;67(5):777–80.CrossRefPubMed
15.
go back to reference Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology. 2001;56(6):753–7.CrossRefPubMed Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology. 2001;56(6):753–7.CrossRefPubMed
16.
go back to reference Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King Jr TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, et al. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med. 2015;3(5):388–96. doi:10.1016/S2213-2600(15)00093-4. Epub 2015 Apr 15.CrossRefPubMedPubMedCentral Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King Jr TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, et al. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med. 2015;3(5):388–96. doi:10.​1016/​S2213-2600(15)00093-4. Epub 2015 Apr 15.CrossRefPubMedPubMedCentral
17.
go back to reference Pinto A, Almeida JP, Pinto S, Pereira J, Oliveira AG, de Carvalho M. Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(11):1238–42.CrossRefPubMed Pinto A, Almeida JP, Pinto S, Pereira J, Oliveira AG, de Carvalho M. Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(11):1238–42.CrossRefPubMed
19.
go back to reference Drigo D, Verriello L, Clagnan E, Eleopra R, Pizzolato G, Bratina A, D’Amico D, Sartori A, Mase G, Simonetto M, et al. The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study. Neuroepidemiology. 2013;41(1):54–61.CrossRefPubMed Drigo D, Verriello L, Clagnan E, Eleopra R, Pizzolato G, Bratina A, D’Amico D, Sartori A, Mase G, Simonetto M, et al. The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study. Neuroepidemiology. 2013;41(1):54–61.CrossRefPubMed
20.
go back to reference Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124(Suppl):96–107.CrossRefPubMed Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124(Suppl):96–107.CrossRefPubMed
21.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–9.CrossRefPubMed Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–9.CrossRefPubMed
23.
go back to reference Albert SM, Whitaker A, Rabkin JG, del Bene M, Tider T, O’Sullivan I, Mitsumoto H. Medical and supportive care among people with ALS in the months before death or tracheostomy. J Pain Symptom Manag. 2009;38(4):546–53. doi:10.1016/j.jpainsymman.2008.11.013. Epub 2009 Jun 18.CrossRef Albert SM, Whitaker A, Rabkin JG, del Bene M, Tider T, O’Sullivan I, Mitsumoto H. Medical and supportive care among people with ALS in the months before death or tracheostomy. J Pain Symptom Manag. 2009;38(4):546–53. doi:10.​1016/​j.​jpainsymman.​2008.​11.​013. Epub 2009 Jun 18.CrossRef
24.
26.
go back to reference Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77(8):948–50.CrossRefPubMedPubMedCentral Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77(8):948–50.CrossRefPubMedPubMedCentral
28.
go back to reference Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20(4):647–54. doi:10.1111/ene.12015. Epub 2012 Oct 25.CrossRefPubMed Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20(4):647–54. doi:10.​1111/​ene.​12015. Epub 2012 Oct 25.CrossRefPubMed
29.
go back to reference Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, Van den Berg LH. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(6):638–42. doi:10.1136/jnnp.2010.236752. Epub 2011 Apr 6.CrossRefPubMed Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, Van den Berg LH. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(6):638–42. doi:10.​1136/​jnnp.​2010.​236752. Epub 2011 Apr 6.CrossRefPubMed
30.
go back to reference Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83(4):395–8. doi:10.1136/jnnp-2011-301161. Epub 2011 Nov 9.CrossRefPubMed Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83(4):395–8. doi:10.​1136/​jnnp-2011-301161. Epub 2011 Nov 9.CrossRefPubMed
31.
go back to reference Wolf J, Safer A, Wohrle JC, Palm F, Nix WA, Maschke M, Grau AJ. Factors Predicting Survival in ALS Patients–Data from a Population-Based Registry in Rhineland-Palatinate, Germany. Neuroepidemiology. 2015;44(3):149–55. doi:10.1159/000381625. Epub 2015 Apr 21.CrossRefPubMed Wolf J, Safer A, Wohrle JC, Palm F, Nix WA, Maschke M, Grau AJ. Factors Predicting Survival in ALS Patients–Data from a Population-Based Registry in Rhineland-Palatinate, Germany. Neuroepidemiology. 2015;44(3):149–55. doi:10.​1159/​000381625. Epub 2015 Apr 21.CrossRefPubMed
32.
go back to reference Keren N, Scott KM, Tsuda M, Barnwell J, Knibb JA, Ellis CM, Leigh PN, Shaw CE, Al-Chalabi A. Evidence of an environmental effect on survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):528–33. doi:10.3109/21678421.2014.911326. Epub 2014 May 27.CrossRefPubMed Keren N, Scott KM, Tsuda M, Barnwell J, Knibb JA, Ellis CM, Leigh PN, Shaw CE, Al-Chalabi A. Evidence of an environmental effect on survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):528–33. doi:10.​3109/​21678421.​2014.​911326. Epub 2014 May 27.CrossRefPubMed
33.
go back to reference Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628–34. doi:10.1136/jnnp.2010.211474. Epub 2010 Nov 19.CrossRefPubMed Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628–34. doi:10.​1136/​jnnp.​2010.​211474. Epub 2010 Nov 19.CrossRefPubMed
Metadata
Title
Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort study
Authors
Federica Edith Pisa
Giancarlo Logroscino
Paolo Giacomelli Battiston
Fabio Barbone
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2016
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-016-0297-y

Other articles of this Issue 1/2016

BMC Pulmonary Medicine 1/2016 Go to the issue